Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Baxter
McKesson
Medtronic
Colorcon

Last Updated: November 16, 2019

DrugPatentWatch Database Preview

Litigation Details for AVENTIS PHARMACEUTICALS INC. v. SUN PHARMA GLOBAL INC. (D.N.J. )

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in AVENTIS PHARMACEUTICALS INC. v. SUN PHARMA GLOBAL INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for AVENTIS PHARMACEUTICALS INC. v. SUN PHARMA GLOBAL INC. (D.N.J. )

Date Filed Document No. Description Snippet Link To Document
2011-01-11 109 “‘974 patent”), 5,855,912 (the “‘912 patent”), 6,113,942 (the “‘942 patent”), and 5,738,872 (the “…the patents are the “Method Patents” – United States Patent Numbers 6,037,353 (the “‘353 patent”), …,187,791 (the “‘791 patent”), and 6,399,632 (the “‘632 patent”). These patents share an identical…United States Patent Numbers 7,390,906 (the “‘906 patent”) and 5,750,703 (the “‘703 patent”). These patents…and ‘632 patents, four (4) terms from the ‘974 patent, two (2) terms from the ‘703 patent, and three External link to document
2011-01-13 110 PageID: 3424 Number 4,254,129. Instead, the ‘791 and ‘632 patents claim a method for the administration…the patents are the “Method Patents” – United States Patent Numbers 6,037,353 (the “‘353 patent”), …States Patent Numbers 7,390,906 (the “‘906 patent”) and 5,750,703 (the “‘703 patent”). These patents also…,187,791 (the “‘791 patent”), and 6,399,632 (the “‘632 patent”). These patents share an identical…6,039,974 (the “‘974 patent”), 5,855,912 (the “‘912 patent”), 6,113,942 (the “‘942 patent”), and 5,738,872 External link to document
2011-01-31 115 that attained by the prior art (e.g., U.S. Patent Nos. 4,254,129, 4,254,130, 4,285,957 and 4,285,958 to Carr…the patents are the “Method Patents” - United States Patent Numbers 6,03 7,3 53 (the “‘353 patent”), 6,187,791…States Patent Numbers 7,390,906 (the “‘906 patent”) and 5,750,703 (the “‘703 patent”). These patents also…the ‘703 patent. (Compare ‘703 patent, 23:45-24:6, with ‘906 patent, 22:33-58). Both patents share substantially…the ‘610 patent, which issued prior to the ‘703 patent. After the ‘610 patent issued, the Patent and Trademark External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
McKesson
Moodys
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.